BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11844142)

  • 1. Polymorphism in the Y box controls level of cytokine-mediated expression of HLA-DRB1 genes.
    Sindwani S; Singal DP
    Tissue Antigens; 2001 Nov; 58(5):315-23. PubMed ID: 11844142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism in both X and Y box motifs controls level of expression of HLA-DRB1 genes.
    Singal DP; Qiu X
    Immunogenetics; 1996; 43(1-2):50-6. PubMed ID: 8537121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence.
    Emery P; Mach B; Reith W
    Hum Immunol; 1993 Oct; 38(2):137-47. PubMed ID: 8106268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential transcriptional activities of HLA-DR genes in the various haplotypes.
    Louis P; Vincent R; Cavadore P; Clot J; Eliaou JF
    J Immunol; 1994 Dec; 153(11):5059-67. PubMed ID: 7963565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole.
    Montani V; Shong M; Taniguchi SI; Suzuki K; Giuliani C; Napolitano G; Saito J; Saji M; Fiorentino B; Reimold AM; Singer DS; Kohn LD
    Endocrinology; 1998 Jan; 139(1):290-302. PubMed ID: 9421427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of the expression of the HLA-DRB genes at the transcriptional level by competitive polymerase chain reaction.
    Vincent R; Louis P; Gongora C; Papa I; Clot J; Eliaou JF
    J Immunol; 1996 Jan; 156(2):603-10. PubMed ID: 8543811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism in the upstream regulatory region and level of expression of HLA-DRB genes.
    Singal DP; Qiu X
    Mol Immunol; 1994 Oct; 31(14):1117-20. PubMed ID: 7523867
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
    Wright KL; Ting JP
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes.
    Panek RB; Moses H; Ting JP; Benveniste EN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11518-22. PubMed ID: 1454841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of HLA class II genes associated with disease susceptibility and progression in rheumatoid arthritis.
    Heldt C; Listing J; Sözeri O; Bläsing F; Frischbutter S; Müller B
    Arthritis Rheum; 2003 Oct; 48(10):2779-87. PubMed ID: 14558083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HLA-DRB9 gene and the origin of HLA-DR haplotypes.
    Gongora R; Figueroa F; Klein J
    Hum Immunol; 1996 Nov; 51(1):23-31. PubMed ID: 8911994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor.
    Hornell TM; Beresford GW; Bushey A; Boss JM; Mellins ED
    J Immunol; 2003 Sep; 171(5):2374-83. PubMed ID: 12928384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
    Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
    Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic polymorphism in the upstream regulatory region of HLA-DRB genes: functional role of conserved consensus motifs.
    Qiu X; Singal DP
    Transplant Proc; 1995 Feb; 27(1):682-3. PubMed ID: 7879144
    [No Abstract]   [Full Text] [Related]  

  • 16. Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease.
    Kawasaki A; Tsuchiya N; Hagiwara K; Takazoe M; Tokunaga K
    Genes Immun; 2000 Aug; 1(6):351-7. PubMed ID: 11196680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
    Nolan D; Castley A; Tschochner M; James I; Qiu W; Sayer D; Christiansen FT; Witt C; Mastaglia F; Carroll W; Kermode A
    Neurology; 2012 Aug; 79(6):538-46. PubMed ID: 22786591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cis-acting sequences required for class II gene regulation by interferon gamma and tumor necrosis factor alpha in a murine macrophage cell line.
    Freund YR; Dedrick RL; Jones PP
    J Exp Med; 1990 Apr; 171(4):1283-99. PubMed ID: 2109037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma.
    Dorak MT; Yee LJ; Tang J; Shao W; Lobashevsky ES; Jacobson LP; Kaslow RA
    J Med Virol; 2005 Jul; 76(3):302-10. PubMed ID: 15902698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele typing of human TNFA 5'-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): linkage disequilibrium with HLA class I and class II genes in Japanese.
    Matsushita M; Tsuchiya N; Nakayama T; Ohashi J; Shibue T; Shiota M; Oka T; Yamane A; Tokunaga K
    Tissue Antigens; 1999 Nov; 54(5):478-84. PubMed ID: 10599887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.